Jakob Dupont - Insider Trading & Ownership

Entity
Individual
Location
C/O Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City, CA
Summary
The estimated net worth of Jakob Dupont is at least $1.67M dollars as of September 6, 2024. Jakob Dupont is the Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $1.56M. Jakob Dupont is the EVP, Head of R&D of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $113K.
All Insider Reports
All Insider Reports

Ownership of Jakob Dupont

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PYXS Pyxis Oncology, Inc. Director $1.56M Mar 26, 2024
ATRA Atara Biotherapeutics, Inc. EVP, Head of R&D $113K Mar 2, 2023
APGN Apexigen, Inc. Director Aug 23, 2023
BOLT Bolt Biotherapeutics, Inc. Director Sep 3, 2024

Insider Transactions Reported by Jakob Dupont:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.